Evidence map›Paper›PMID 41234936›Full record

ArticleFrontiers in neurology2025

Predictive value of cerebral perfusion and guanine nucleotide-binding protein, alpha-stimulating activity polypeptide in ischemic white matter lesions: a machine learning approach.

Ning Yu, Shuai Ma, Zongkai Wu, Zhijie Dou, Shengxian Jiao, Yajing Li, Hebo Wang, Xiaoxuan Zhang

Abstract read
In one paragraph

Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ning Yu *Department of Neurology, Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China.
Shuai Ma *Institute of Traditional Chinese Medicine, Chengde Medical University, Chengde, Hebei, China.
Zongkai WuDepartment of Neurology, Hebei General Hospital, Shijiazhuang, Hebei, China.
Zhijie DouDepartment of Neurology, Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China.
Shengxian JiaoDepartment of Neurology, Hebei General Hospital, Shijiazhuang, Hebei, China.
Yajing LiDepartment of Neurology, Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China.
Hebo WangDepartment of Neurology, Hebei General Hospital, Shijiazhuang, Hebei, China.
Xiaoxuan ZhangDepartment of Neurology, Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To assess the predictive value of guanine nucleotide-binding protein, alpha-stimulating activity polypeptide (GNAS) and cerebral perfusion in various vascular regions for the severity of ischemic white matter lesions (WMLs). Methods: Patients hospitalized at the Neurology Department of the Affiliated Hospital of Chengde Medical University between April and November 2023 were evaluated for ischemic cerebral WMLs using magnetic resonance imaging. In this retrospective cohort study, patients were classified into two groups: mild and severe, based on Fazekas scores. White matter perfusion was assessed using image segmentation of arterial spin labeling sequence images. Predictive variables were identified via machine learning (ML). GNAS levels in peripheral blood were measured to explore their association with WML severity. Results: Among 85 patients (43 mild [24 males and 19 females], 42 severe [27 males and 15 females]), significant differences were observed in age (64.00 ± 8.47 years vs. 68.38 ± 10.85 years, Conclusion: In patients with ischemic WMLs, factors such as age, sex, history of cerebral infarction, GNAS levels, and specific perfusion metrics are predictive of WML progression. Advanced imaging and ML improve detection. GNAS levels correlated with Fazekas scores, indicating their downregulation in the hypoperfused white matter.

Indexed as

alpha-stimulating activity polypeptidearterial spin labelingcerebral perfusionguanine nucleotide-binding proteinwhite matter lesion

Identifiers

PMID41234936
PMCPMC12605113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.